CareFusion 202, Inc., a prominent player in the medical technology industry, is headquartered in the United States. Founded in 2009, the company has rapidly established itself as a leader in the development of innovative healthcare solutions, particularly in the areas of medication management and infection prevention. With a strong operational presence across North America and Europe, CareFusion offers a diverse range of core products, including infusion systems, respiratory devices, and surgical instruments. These products are distinguished by their commitment to enhancing patient safety and improving clinical outcomes. Recognised for its cutting-edge technology and dedication to quality, CareFusion has achieved significant milestones, positioning itself as a trusted partner in the healthcare sector. The company continues to drive advancements that support healthcare professionals and improve patient care globally.
How does CareFusion 202, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
CareFusion 202, Inc.'s score of 23 is lower than 71% of the industry. This can give you a sense of how well the company is doing compared to its peers.
CareFusion 202, Inc., headquartered in the US, currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Furthermore, the company has not established any documented reduction targets or climate pledges, which suggests a lack of formal commitments to address carbon emissions at this time. As there are no emissions data or reduction initiatives available, CareFusion 202, Inc. appears to be in the early stages of developing a comprehensive climate strategy. In the context of the industry, many companies are increasingly adopting science-based targets and sustainability initiatives to mitigate their environmental impact. However, without specific commitments or data, it is unclear how CareFusion 202, Inc. plans to align with these industry standards.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
CareFusion 202, Inc. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.

